Related content

Valsartan: A Review of its Use in Patients with Heart Failure and/or Left Ventricular Systolic Dysfunction After Myocardial Infarction

By Katherine F. Croom   Gillian M. Keating  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-404

Adis International

Access to resources Recommend Favorite

In-Hospital Heart Rate Turbulence and Microvolt T-Wave Alternans Abnormalities for Prediction of Early Life-Threatening Ventricular Arrhythmia after Acute Myocardial Infarction

By Arisha Mohamed Moussa   Girerd Nicolas   Chauveau Samuel   Bresson Didier   Scridon Alina   Bonnefoy Eric   Chevalier Philippe  

Annals of Noninvasive Electrocardiology, Vol. 18, Iss. 6, 2013-11 ,pp. : 530-537

Blackwell Publishing

Access to resources Recommend Favorite

Losartan and acute myocardial infarction in insulin-resistant Zucker fatty rats: reduced ventricular arrhythmias and improved survival

By Pourdjabbar Ali   Parker Thomas G   Desjardins Jean-François   Nguyen Quang T.   Tsoporis James N   Lapointe Nathalie   Rouleau Jean-Lucien  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 11, 2005-11 ,pp. : 989-998

NRC Research Press

Access to resources Recommend Favorite

Bone marrow infusion improves left ventricular function after myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Azimilide reduced the incidence of atrial fibrillation (AF) but had no effect on mortality in patients with left ventricular dysfunction after recent myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite